Editas Medicine
EDIT
#7167
Rank
C$0.43 B
Marketcap
$5.30
Share price
0.77%
Change (1 day)
-50.48%
Change (1 year)

Operating Margin for Editas Medicine (EDIT)

Operating Margin as of September 2024 (TTM): -317.78%

According to Editas Medicine 's latest financial reports and stock price the company's current Operating Margin is -317.78%. At the end of 2023 the company had an Operating Margin of -196.13%.

Operating Margin history for Editas Medicine from 2016 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-196.13%-82.46%
2022-1,118.26%48.39%
2021-753.61%489.57%
2020-127.82%-80.38%
2019-651.43%89.21%
2018-344.28%-60.72%
2017-876.49%-45.41%
2016-1,605.53%-64.12%
2015-4,475.14%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-25.56%-91.96% Jersey
-97.60%-69.29%๐Ÿ‡บ๐Ÿ‡ธ USA
-9,470.94% 2,880.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-129.00%-59.41%๐Ÿ‡ฌ๐Ÿ‡ง UK

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.